Does ALECTINIB Cause Disease progression? 366 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 366 reports of Disease progression have been filed in association with ALECTINIB (ALECENSA). This represents 4.0% of all adverse event reports for ALECTINIB.
366
Reports of Disease progression with ALECTINIB
4.0%
of all ALECTINIB reports
64
Deaths
31
Hospitalizations
How Dangerous Is Disease progression From ALECTINIB?
Of the 366 reports, 64 (17.5%) resulted in death, 31 (8.5%) required hospitalization, and 8 (2.2%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALECTINIB. However, 366 reports have been filed with the FAERS database.
What Other Side Effects Does ALECTINIB Cause?
Death (702)
Fatigue (618)
Constipation (525)
Off label use (495)
No adverse event (488)
Rash (312)
Dyspnoea (296)
Drug ineffective (269)
Myalgia (268)
Anaemia (267)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which ALECTINIB Alternatives Have Lower Disease progression Risk?
ALECTINIB vs ALEMTUZUMAB
ALECTINIB vs ALENDRONATE
ALECTINIB vs ALENDRONATE\CHOLECALCIFEROL
ALECTINIB vs ALENDRONIC ACID
ALECTINIB vs ALEVE